Kymera Therapeutics, Inc.
KYMR
Hisse Senetlerindeki Sıralama
#2179
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Hisse Fiyatı
$114.06
Son senkronizasyon: 2026-10-20
Piyasa Değeri
$9.38B
Değişim (1 gün)
5.54%
Değişim (1 yıl)
95.57%
Ülke
US
Ticaret Kymera Therapeutics, Inc. (KYMR)
Kategori
Healthcare
Kymera Therapeutics, Inc. (KYMR) için gelir
Jun 2026 itibarıyla gelir TTM: $104.99M
Kymera Therapeutics, Inc. şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $104.99M'dir. 2023 yılında şirketin geliri $78.59M önceki yıla göre artış 2022 yılındaki $46.83M gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Kymera Therapeutics, Inc. için 2018 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
| Yıl | Gelir | Değiştir |
|---|---|---|
| 2026 (TTM) | $104.99M | 123.04% |
| 2024 | $47.07M | -40.11% |
| 2023 | $78.59M | 67.84% |
| 2022 | $46.83M | -35.71% |
| 2021 | $72.83M | 114.00% |
| 2020 | $34.03M | 1,059.99% |
| 2019 | $2.93M | 0.00% |
| 2018 | 0.00 | 0.00% |
Benzer şirketler veya rakiplerin geliri
| Şirket | Gelir | Gelir Farkı | Ülke |
|---|---|---|---|
| $12.62B | 11,924.40% |
US
|
|
| $2.23B | 2,022.13% |
US
|
|
| $15.74B | 14,896.17% |
AU
|
|
| - | - |
CH
|
|
| $6.02B | 5,635.16% |
NL
|
